Equities research analysts predict that Docusign Inc (NASDAQ:DOCU) will report earnings of $0.04 per share for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for Docusign’s earnings, with the highest EPS estimate coming in at $0.05 and the lowest estimate coming in at $0.03. Docusign reported earnings of $0.03 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 33.3%. The business is expected to announce its next earnings results after the market closes on Thursday, September 5th.
According to Zacks, analysts expect that Docusign will report full-year earnings of $0.19 per share for the current year, with EPS estimates ranging from $0.15 to $0.24. For the next financial year, analysts expect that the business will report earnings of $0.38 per share, with EPS estimates ranging from $0.29 to $0.52. Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that cover Docusign.
Docusign (NASDAQ:DOCU) last released its quarterly earnings results on Thursday, June 6th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.23) by $0.30. The firm had revenue of $213.96 million during the quarter, compared to the consensus estimate of $208.15 million. Docusign had a negative net margin of 26.54% and a negative return on equity of 22.27%. Docusign’s revenue for the quarter was up 37.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.01 EPS.
In other Docusign news, COO Scott V. Olrich sold 10,000 shares of the company’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $53.48, for a total value of $534,800.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Peter Solvik sold 541,532 shares of the company’s stock in a transaction dated Tuesday, July 9th. The shares were sold at an average price of $51.52, for a total transaction of $27,899,728.64. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 580,988 shares of company stock worth $29,984,781. 13.60% of the stock is owned by insiders.
Large investors have recently added to or reduced their stakes in the business. Clean Yield Group purchased a new position in shares of Docusign during the 1st quarter worth about $31,000. Wealthcare Advisory Partners LLC purchased a new position in Docusign in the second quarter valued at approximately $36,000. Migdal Insurance & Financial Holdings Ltd. raised its holdings in Docusign by 261.0% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 769 shares of the company’s stock valued at $38,000 after buying an additional 556 shares during the period. Rehmann Capital Advisory Group raised its holdings in Docusign by 226.1% in the first quarter. Rehmann Capital Advisory Group now owns 874 shares of the company’s stock valued at $45,000 after buying an additional 606 shares during the period. Finally, FNY Investment Advisers LLC purchased a new position in Docusign in the second quarter valued at approximately $47,000. Institutional investors own 61.49% of the company’s stock.
Shares of NASDAQ:DOCU traded down $0.75 on Friday, reaching $43.98. 1,156,437 shares of the company were exchanged, compared to its average volume of 2,043,411. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 1.00. Docusign has a 1-year low of $35.06 and a 1-year high of $68.35. The firm has a market cap of $7.78 billion, a price-to-earnings ratio of -15.17 and a beta of 1.31. The company has a 50-day moving average of $49.63 and a 200-day moving average of $52.66.
DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.